Literature DB >> 10512238

Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity.

S C Coley1, D A Porter, F Calamante, W K Chong, A Connelly.   

Abstract

Apparent diffusion coefficient maps of two patients with cyclosporine-induced neurotoxicity showed areas of increased diffusion that corresponded to the characteristic regions of signal change on routine T2-weighted sequences. The majority of lesions subsequently resolved without residual T2 or diffusion signal alteration. These findings suggest that, in our patients, the neurotoxic effects of cyclosporine resulted in a partially reversible extravasation of fluid into the cerebral interstitium and were not associated with acute ischemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512238      PMCID: PMC7657742     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  19 in total

1.  Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain.

Authors:  J V Hajnal; D J Bryant; L Kasuboski; P M Pattany; B De Coene; P D Lewis; J M Pennock; A Oatridge; I R Young; G M Bydder
Journal:  J Comput Assist Tomogr       Date:  1992 Nov-Dec       Impact factor: 1.826

2.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

3.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

4.  Cyclosporin-induced endothelial cell injury.

Authors:  C Zoja; L Furci; F Ghilardi; P Zilio; A Benigni; G Remuzzi
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

5.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

6.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

7.  Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.

Authors:  D E Reece; D A Frei-Lahr; J D Shepherd; K Dorovini-Zis; R D Gascoyne; D A Graeb; J J Spinelli; M J Barnett; H G Klingemann; G P Herzig
Journal:  Bone Marrow Transplant       Date:  1991-11       Impact factor: 5.483

8.  Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions.

Authors:  R A Hauser; D M Lacey; M R Knight
Journal:  Arch Neurol       Date:  1988-10

9.  Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis.

Authors:  R B Schwartz; R V Mulkern; H Gudbjartsson; F Jolesz
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

10.  Cerebral blindness and encephalopathy with cyclosporin A toxicity.

Authors:  A M Rubin; H Kang
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

View more
  14 in total

1.  Diffusion-weighted MR imaging of the normal human spinal cord in vivo.

Authors:  C A Holder; R Muthupillai; S Mukundan; J D Eastwood; P A Hudgins
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

2.  Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.

Authors:  J M Provenzale; J R Petrella; L C Cruz; J C Wong; S Engelter; D P Barboriak
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Stroke is an important paediatric illness.

Authors:  W K Kling Chong; Dawn E Saunders; Vijeya Ganesan
Journal:  Pediatr Radiol       Date:  2003-11-28

4.  The use of cyclosporine in a boy with a prior episode of posterior encephalopathy.

Authors:  Chieko Nakahara; Naoyuki Hasegawa; Isho Izumi; Katsuyosi Kanemoto; Nobuaki Iwasaki
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

5.  Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Kendra R Parris; Kathryn M Russell; Brandon M Triplett; Sean Phipps
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

6.  NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.

Authors:  Susan K Parsons; Sean Phipps; Lillian Sung; K Scott Baker; Michael A Pulsipher; Kirsten K Ness
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

7.  Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.

Authors:  Elizabeth I Pierpont; Julie B Eisengart; Ryan Shanley; David Nascene; Gerald V Raymond; Elsa G Shapiro; Rich S Ziegler; Paul J Orchard; Weston P Miller
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

8.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

9.  Brain stem hypertensive encephalopathy evaluated by line scan diffusion-weighted imaging.

Authors:  Motonori Nagata; Masayuki Maeda; Hirokazu Tsukahara; Stephan E Maier; Ken Takeda
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

10.  Posterior encephalopathy with vasospasm: MRI and angiography.

Authors:  S Weidauer; J Gaa; M Sitzer; R Hefner; H Lanfermann; F E Zanella
Journal:  Neuroradiology       Date:  2003-10-22       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.